Cencora Inc. (COR) shares fell 5.35% in pre-market trading following the release of the company's fiscal first quarter 2026 results.
The healthcare solutions provider reported quarterly revenue of $85.932 billion, which missed the analyst consensus estimate of $86.027 billion. This represents a 5.45% increase over sales from the same period last year but fell short of expectations.
While Cencora's adjusted earnings per share of $4.08 exceeded the $4.04 estimate, investors appeared focused on the revenue shortfall. The company also provided fiscal 2026 guidance with adjusted EPS expected in the range of $17.45 to $17.75.